Top Markets
Coin of the day
Pathkey.AI Ltd Pathkey.AI Ltd

Pathkey.AI Ltd

PKY
Rank in Stocks #27639
Pathkey.AI Ltd is an Australian digital health firm that harnesses artificial... Pathkey.AI Ltd is an Australian digital health firm that harnesses artificial intelligence (AI) to advance clinical trials and improve the predictability of patient outcomes, particularly within Australia. The company presents a suite of AI-driven solutions: TrialKey, a sophisticated platform for simulating and optimizing trial designs to boost success rates, and TrialGen, an AI-powered utility crafted to simplify the clinical trial design process. They extend their services to a diverse clientele, encompassing biopharmaceutical companies, MedTech innovators, governmental agencies, and various healthcare organizations. Established in Sydney in 1994, the entity known today as Pathkey.AI Ltd will formally change its name from Opyl Limited in August 2025.
Share Price
$0.02539025
Market Cap
$31.56M
Change (1 day)
0.00%
Change (1 year)
71.58%
Country
AU
Trade Pathkey.AI Ltd (PKY)

Category

P/S ratio for Pathkey.AI Ltd (PKY)
P/S ratio as of 2026 TTM: 0
According to Pathkey.AI Ltd latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Pathkey.AI Ltd from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors